Clinical Trials
5
Active:0
Completed:4
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Nalagenetics Pte Ltd
- Target Recruit Count
- 322
- Registration Number
- NCT05570266
- Locations
- 🇮🇩
MRCC Siloam Hospitals Semanggi, Jakarta, Jakarta Raya, Indonesia
The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Nalagenetics Pte Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT05562440
- Locations
- 🇮🇩
MRCCC Siloam Hospitals Semanggi, Jakarta, DKI Jakarta, Indonesia
Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)
Completed
- Conditions
- Pre-emptive Pharmacogenomics
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Nalagenetics Pte Ltd
- Target Recruit Count
- 222
- Registration Number
- NCT05504135
- Locations
- 🇸🇬
Raffles Hospital, Singapore, Singapore
CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- Nalagenetics Pte Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT05501158
- Locations
- 🇮🇩
MRCCC Siloam Hospitals Semanggi, Jakarta, DKI Jakarta, Indonesia
Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Nalagenetics Pte Ltd
- Target Recruit Count
- 151
- Registration Number
- NCT04312347
- Locations
- 🇮🇩
MRCCC Siloam Hospital Semanggi, Jakarta, DKI Jakarta, Indonesia
News
No news found